North Star Investment Management’s Haemonetics HAE Stock Holding History

North Star Investment Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,675	Closed	-$349K	–	1328
2025 Q2	$349K	Hold	4,675	–	–	0.02%	348
2025 Q1	$297K	Hold	4,675	–	–	0.02%	368
2024 Q4	$365K	Hold	4,675	–	–	0.03%	349
2024 Q3	$376K	Hold	4,675	–	–	0.03%	353
2024 Q2	$387K	Hold	4,675	–	–	0.03%	349
2024 Q1	$399K	Hold	4,675	–	–	0.03%	353
2023 Q4	$400K	Hold	4,675	–	–	0.03%	352
2023 Q3	$419K	Sell	4,675 -4,715	-50%	-$421K	0.04%	345
2023 Q2	$799K	Hold	9,390	–	–	0.06%	266
2023 Q1	$777K	Hold	9,390	–	–	0.06%	275
2022 Q4	$739K	Buy	+9,390	New	+$755K	0.07%	282

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

North Star Investment Management's HAE Position: Q3 2025 in Review

North Star Investment Management sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 4,675 shares — an estimated $349K sold.

North Star Investment Management first reported a position in HAE in Q4 2022 and held it in 11 quarters. The position peaked at $799K in Q2 2023. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

North Star Investment Management reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
North Star Investment Management sold 4,675 Haemonetics shares in Q3 2025, an estimated $349K.
North Star Investment Management first reported a position in Haemonetics in Q4 2022 and held it in 11 quarters.
North Star Investment Management's Haemonetics position peaked at $799K in Q2 2023.
301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on North Star Investment Management's 13F filing for Q3 2025, filed 22 Oct 2025.